Placenta accreta spectrum

From WikiMD's Wellness Encyclopedia

Placenta accreta spectrum (PAS) is a complication of pregnancy characterized by the abnormal adherence of the placenta to the myometrium, the middle layer of the wall of the uterus. It is a significant cause of maternal mortality and morbidity worldwide.

Classification[edit | edit source]

PAS is classified into three types based on the depth of placental invasion into the uterine wall:

  • Placenta accreta: The placenta attaches too deeply and firmly, but it does not penetrate the uterine muscle.
  • Placenta increta: The placenta attaches even more deeply, invading the muscle.
  • Placenta percreta: The placenta penetrates through the entire uterine wall and can attach to other organs such as the bladder.

Risk factors[edit | edit source]

The primary risk factor for PAS is placenta previa in the presence of a uterine scar, typically from a previous cesarean section. Other risk factors include advanced maternal age, high parity, and previous uterine surgery or curettage.

Diagnosis[edit | edit source]

PAS is typically diagnosed through ultrasound during the second or third trimester of pregnancy. Magnetic resonance imaging (MRI) may also be used if ultrasound results are inconclusive.

Treatment[edit | edit source]

The treatment for PAS is usually planned cesarean delivery followed by hysterectomy. In some cases, conservative management may be considered, where the placenta is left in place and allowed to resorb naturally.

Prognosis[edit | edit source]

The prognosis for PAS depends on the severity of the condition, the woman's overall health, and the quality of medical care received. With appropriate management, most women with PAS can expect a good outcome.

See also[edit | edit source]

Placenta accreta spectrum Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD